Sonnet BioTherapeutics (SONN) Insider Trading & Ownership $1.26 +0.03 (+2.44%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$1.28 +0.02 (+1.59%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Sonnet BioTherapeutics (NASDAQ:SONN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.00%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$105,416.74Number OfInsiders Selling(Last 3 Years)0 Get SONN Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SONN Insider Buying and Selling by Quarter Sonnet BioTherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/14/2023Susan DexterInsiderBuy454$15.40$6,991.60 5/30/2023Albert D DyrnessDirectorBuy1,057$10.34$10,929.38 5/17/2023Nailesh BhattDirectorBuy1,136$5.06$5,748.16 5/15/2023Pankaj MohanCEOBuy16,890$4.84$81,747.60 (Data available from 1/1/2013 forward) SONN Insider Trading Activity - Frequently Asked Questions Who is on Sonnet BioTherapeutics's Insider Roster? The list of insiders at Sonnet BioTherapeutics includes Albert D Dyrness, Nailesh Bhatt, Pankaj Mohan, and Susan Dexter. Learn more on insiders at SONN. What percentage of Sonnet BioTherapeutics stock is owned by insiders? 2.00% of Sonnet BioTherapeutics stock is owned by insiders. Learn more on SONN's insider holdings. Which Sonnet BioTherapeutics insiders have been buying company stock? The following insiders have purchased SONN shares in the last 24 months: Albert D Dyrness ($10,929.38), Nailesh Bhatt ($5,748.16), Pankaj Mohan ($81,747.60), and Susan Dexter ($6,991.60). How much insider buying is happening at Sonnet BioTherapeutics? Insiders have purchased a total of 19,537 SONN shares in the last 24 months for a total of $105,416.74 bought. Sonnet BioTherapeutics Key ExecutivesDr. Pankaj Mohan Ph.D. (Age 59)Founder, Chairman, CEO & President Compensation: $927kDr. John K. Cini Ph.D. (Age 71)Chief Scientific Officer & Co-Founder Compensation: $602.48kMr. Jay Cross (Age 53)Chief Financial Officer Compensation: $603.42kMr. Donald J. Griffith CPA (Age 75)CPA, Controller & Director Compensation: $134.05kMs. Susan Dexter (Age 69)Chief Technical Officer Dr. Richard T. Kenney FACP (Age 66)M.D., Chief Medical Officer Mr. Manuel DafonsecaHead of Clinical Operations More Insider Trading Tools from MarketBeat Related Companies UBX Insider Ownership BCTX Insider Ownership EGRX Insider Ownership BIVI Insider Ownership SNYR Insider Ownership CING Insider Ownership MIRA Insider Ownership GOVX Insider Ownership GLYC Insider Ownership CLRB Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:SONN) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SONN Stock Free SONN Stock Alerts